Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes

ClinicalTrials.gov ID: NCT02034513

Public ClinicalTrials.gov record NCT02034513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (SWITCH 1)

Study identification

NCT ID
NCT02034513
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
501 participants

Conditions and interventions

Interventions

  • insulin aspart Drug
  • insulin degludec Drug
  • insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2014
Primary completion
Jan 10, 2016
Completion
Jan 10, 2016
Last update posted
Jan 1, 2019

2014 – 2016

United States locations

U.S. sites
92
U.S. states
30
U.S. cities
84
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35215-7502
Novo Nordisk Investigational Site Goodyear Arizona 85395
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site Long Beach California 90807
Novo Nordisk Investigational Site Rancho Cucamonga California 91730-3063
Novo Nordisk Investigational Site San Mateo California 94401
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Santa Monica California 90404
Novo Nordisk Investigational Site Upland California 91786
Novo Nordisk Investigational Site Ventura California 93003
Novo Nordisk Investigational Site Denver Colorado 80220
Novo Nordisk Investigational Site Cooper City Florida 33024
Novo Nordisk Investigational Site Fleming Island Florida 32003
Novo Nordisk Investigational Site Fort Lauderdale Florida 33312
Novo Nordisk Investigational Site Hialeah Florida 33012
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Jacksonville Florida 32207
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Jacksonville Florida 32256
Novo Nordisk Investigational Site Miami Florida 33130
Novo Nordisk Investigational Site Miami Florida 33156
Novo Nordisk Investigational Site Miami Florida 33175
Novo Nordisk Investigational Site Miami Springs Florida 33166
Novo Nordisk Investigational Site New Port Richey Florida 34652
Novo Nordisk Investigational Site Pembroke Pines Florida 33026
Novo Nordisk Investigational Site Port Charlotte Florida 33952
Novo Nordisk Investigational Site Port Orange Florida 32127
Novo Nordisk Investigational Site Lawrenceville Georgia 30046
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Arlington Heights Illinois 60005-4144
Novo Nordisk Investigational Site Chicago Illinois 60611
Novo Nordisk Investigational Site Crystal Lake Illinois 60012
Novo Nordisk Investigational Site Skokie Illinois 60077
Novo Nordisk Investigational Site Anderson Indiana 46011
Novo Nordisk Investigational Site Indianapolis Indiana 46234
Novo Nordisk Investigational Site Council Bluffs Iowa 51501
Novo Nordisk Investigational Site West Des Moines Iowa 50265
Novo Nordisk Investigational Site Lenexa Kansas 66219
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Livonia Michigan 48152
Novo Nordisk Investigational Site Hazelwood Missouri 63042
Novo Nordisk Investigational Site Jefferson City Missouri 65109
Novo Nordisk Investigational Site Kansas City Missouri 64106
Novo Nordisk Investigational Site Billings Montana 59101
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Henderson Nevada 89052-2649
Novo Nordisk Investigational Site Las Vegas Nevada 89148
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Hamilton New Jersey 08690
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site Harrison New York 10528
Novo Nordisk Investigational Site Mineola New York 11501
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Morehead City North Carolina 28557
Novo Nordisk Investigational Site Raleigh North Carolina 27609
Novo Nordisk Investigational Site Toledo Ohio 43614
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104
Novo Nordisk Investigational Site Jenkintown Pennsylvania 19046
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Austin Texas 78758
Novo Nordisk Investigational Site Carrollton Texas 75007
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site El Paso Texas 79912
Novo Nordisk Investigational Site Houston Texas 77024
Novo Nordisk Investigational Site Houston Texas 77079
Novo Nordisk Investigational Site Katy Texas 77450
Novo Nordisk Investigational Site Mesquite Texas 75149
Novo Nordisk Investigational Site Richardson Texas 75080
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Schertz Texas 78154
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Salt Lake City Utah 84102
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site Chesapeake Virginia 23321
Novo Nordisk Investigational Site Norfolk Virginia 23510
Novo Nordisk Investigational Site Federal Way Washington 98003
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Richland Washington 99352
Novo Nordisk Investigational Site Spokane Washington 99208
Novo Nordisk Investigational Site Walla Walla Washington 99362-4445
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02034513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2019 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02034513 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →